What are the side effects of upatinib? Are these side effects serious, and how can they be prevented and alleviated?

Upadacitinib is an oral JAK1 selective inhibitor that is widely used to treat a variety of autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. Due to its precise targeting mechanism, upadatinib has shown good efficacy in clinical applications and has become an important drug for many patients to control their disease. However, like all immunomodulators, upadatinib also has a certain risk of side effects. Patients need to pay close attention and maintain communication with their doctors during the medication to ensure the safety of the medication.

Common side effects:

The more common side effects of upadatinib include upper respiratory tract infection, nasopharyngitis, headache, nausea, diarrhea, oral ulcers, etc. These side effects are usually mild, tolerated by most patients, and gradually lessen over time. For example, mild cold-like symptoms or gastrointestinal discomfort often resolve on their own without special treatment. However, if these mild side effects last for a long time or the symptoms worsen, the doctor should be informed in time so that the dosage can be adjusted or the treatment plan can be changed.

Serious side effects and risks:

Upadatinib may also cause some serious adverse reactions, especially when taken for a long time or combined with other immunosuppressants, the risks need to be paid attention to. More serious side effects include:

1.Increased risk of infection: Due to suppressed immune system activity, upadacitinib may make patients more susceptible to serious infections, such as pneumonia, shingles, tuberculosis, or fungal infections. It is recommended to undergo tuberculosis screening before taking the medicine, and to closely observe whether signs of infection such as fever, cough, rash, etc. occur during treatment.

2. Blood system abnormalities: Upadatinib can cause blood system changes such as leukopenia and thrombocytopenia, and some patients may develop anemia. Doctors usually monitor blood routine at the beginning of treatment and regularly during treatment to detect and deal with these potential problems in a timely manner.

3.Abnormal liver function: Some patients may experience elevated liver enzymes after taking the drug, such as abnormal increases in AST or ALT, which may lead to liver damage in severe cases. It is recommended to regularly test liver function during medication. If you have a history of liver disease or are taking other drugs that burden the liver, you should be more vigilant.

4.Cardiovascular and thrombotic risks: Studies have shown that upadatinib may slightly increase the risk of cardiovascular events (such as myocardial infarction, stroke) and venous thrombosis (such as deep vein thrombosis, pulmonary embolism), especially in patients with existing hypertension, hyperlipidemia, smoking history, or previous history of thrombosis.

5.Tumor risk: Although rare, long-term use of JAK inhibitors may be associated with a slightly increased risk of certain malignant tumors (such as skin cancer, lymphoma), and regular physical examinations and screenings are required, especially for patients with a family history of cancer.

How to prevent and alleviate side effects:

The key to preventing the side effects of upadatinib lies in standardized medication and regular monitoring. Before starting treatment, doctors usually arrange a comprehensive evaluation, including tuberculosis screening, liver and kidney function, blood routine and other tests, to rule out potential risks. At the same time, patients should strictly follow the doctor's instructions and should not increase or decrease the dosage or stop the medication on their own.

During the treatment process, it is recommended to return to the hospital regularly every 1 to 3 months to review relevant indicators, such as blood routine, liver function, blood lipids and infection markers, so as to detect adverse reactions early and provide timely intervention. For patients at risk of infection, doctors may give preventive vaccines (such as shingles vaccine) or adjust treatment plans to reduce the degree of immunosuppression.

In daily life, patients should maintain good personal hygiene and avoid going to crowded places to reduce the risk of infection; maintain a healthy diet and routine, and avoid drinking alcohol to reduce the burden on the liver; if symptoms such as fever, persistent cough, jaundice, rash or abnormal fatigue occur, they should seek medical treatment immediately.

Upadatinib, as a potent immunomodulator, is of great value in the control of autoimmune diseases. Although its side effects cannot be ignored, most side effects are controllable and reversible with scientific medication, regular monitoring and preventive measures under the guidance of a doctor. Patients should establish a correct concept of medication, and should not blindly fear the side effects of medication, nor take it lightly. Only by closely cooperating with the doctor can the therapeutic effect of the medication be maximized while ensuring safety.

Reference materials:https://www.rinvoq.com/